跳至主要内容
临床试验/CTRI/2023/10/058249
CTRI/2023/10/058249尚未招募3 期

A controlled clinical study to evaluate the effect of Ashwagandha ksheerapaka in the management of Anidra w.s.r. to Primary Insomnia. - NI

Dr Rushikesh Dilip Chalak0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient with classical sign & symptoms of Anidra
  • 2.Patient who are fulfilling the American Psychiatric Association (DSM-IV) diagnostic
  • criteria of Primary Insomnia.
  • 3.Patient with On-going medication of other systemic disorders which does not interfere
  • with the current course of insomnia will be included in the study.

排除标准

  • 1. Patient with Secondary Insomnia.
  • 2.Patient with Alcohol dependency.
  • 3.Patient suffering with major psychiatric disorders and other Systemic disorders.
  • 4.Patient on Hypnotic medications, sedative drugs or any other drugs which causes
  • drowsiness.
  • 5.Patient with Lactose intolerance.
  • 6.Pregnant and lactating women will be excluded.
  • 7.Patient denying consent.

研究者

发起方
Dr Rushikesh Dilip Chalak

相似试验